Shopping Cart
- Remove All
- Your shopping cart is currently empty
MTX-216 is an ATP-competitive inhibitor targeting both PI3K and EGFR. It simultaneously inhibits Ki-67 and ribosomal S6 phosphorylation, inducing apoptosis in NF1LOF cells. Additionally, MTX-216 suppresses SYK kinase activity with an IC50 of 281 nM. This compound is applicable for melanoma research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | MTX-216 is an ATP-competitive inhibitor targeting both PI3K and EGFR. It simultaneously inhibits Ki-67 and ribosomal S6 phosphorylation, inducing apoptosis in NF1LOF cells. Additionally, MTX-216 suppresses SYK kinase activity with an IC50 of 281 nM. This compound is applicable for melanoma research. |
In vitro | MTX-216 exhibits strong inhibitory effects on the growth of NF1 LOF melanoma both in vitro and in vivo. Additionally, MTX-216 suppresses the expression of a group of genes that regulate the mitochondrial electron transport chain. |
In vivo | MTX-216 (50 mg/kg, administered every other day from days 11 to 20, in mice transplanted with COLO792 and WM3918 cells) inhibits tumor growth. |
Molecular Weight | 502.348 |
Formula | C22H14Cl2FN5O2S |
Cas No. | 1952236-19-9 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.